Arthur A. Levin - 13 Mar 2026 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Reporting relationship: Director
Issuer ticker: STOK
Reported as of: 13 Mar 2026
Net transaction value: -$22,264
SEC form: 4
Accepted by SEC: 17 Mar 2026, 17:23:01 UTC
Prior SEC filing: 27 Feb 2026
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Allan, Attorney-in-Fact

Key filing fact

Arthur A. Levin filed Form 4 for Stoke Therapeutics, Inc. (STOK) on 17 Mar 2026.

Key facts

This page summarizes Arthur A. Levin's Form 4 filing for Stoke Therapeutics, Inc. (STOK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Mar 2026, 17:23.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: -$22,264.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001181556 Primary reporting owner

LEVIN ARTHUR A

Relationship: Director
Address: C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD
Signature: /s/ Jonathan Allan, Attorney-in-Fact
Signature date: 17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STOK transaction

Common Stock

Sale

Transaction value: $22,264
Shares: -605
Change %: -12%
Price: $36.80
Shares after: 4,237
Date: 13 Mar 2026
Ownership: Direct
Footnotes: F1

STOK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 17,979
Date: 13 Mar 2026
Ownership: Arthur A. Levin, Ph.D., Trustee, Butler-Levin Revocable Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2025.